Загрузка...
Is Antiplatelet Therapy Contraindicated After Platelet-Rich Plasma Treatment? A Narrative Review
BACKGROUND: Antiplatelet therapies are often withheld before and after platelet-rich plasma product (PRPP) administration due to theoretical concerns that therapies that inhibit the function of platelets would inhibit the effects of PRPP. PURPOSE/HYPOTHESIS: The purpose of this study was to evaluate...
Сохранить в:
| Опубликовано в: : | Orthop J Sports Med |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8202276/ https://ncbi.nlm.nih.gov/pubmed/34179207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/23259671211010510 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|